Serving as the key methyltransferase responsible for m6A modifications, METTL14 was demonstrated to suppress the metastatic potential of hepatocellular carcinoma via m6A-dependent primary microRNA processing events [23]. This evidence concerns the gene METTL14 and hepatocellular carcinoma.